Scienture Drug Patent Portfolio
Scienture owns 1 orange book drug protected by 2 US patents Given below is the list of Scienture's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11890273 | Losartan liquid formulations and methods of use | 07 Oct, 2041 | Active |
| US12156869 | Losartan liquid formulations and methods of use | 07 Oct, 2041 | Active |
Scienture's Family Patents
Scienture Drug List
Given below is the complete list of Scienture's drugs and the patents protecting them.
1. Arbli
Arbli is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11890273 | Losartan liquid formulations and methods of use |
07 Oct, 2041
(16 years from now)
| Active |
| US12156869 | Losartan liquid formulations and methods of use |
07 Oct, 2041
(16 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arbli's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List